Drug
Bcx7353 And Probes
Bcx7353 And Probes: highest development phase Phase 1, developed by BioCryst Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioCryst Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| BCX7353 and probes NCT02819102 | Phase 1 | Hereditary Angioedema |
Latest
No recent events.
Follow Bcx7353 And Probes on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.